AI & Pharma

09:00-12:30, January 28 @ 4BC

Track / Overview

Advances in AI/ML are seen critical to advance our understanding of the disease and to bring better and more efficacious treatments to patients. As part of the drug development life-cycle vast amounts of clinical trials data are collected in order to identify targets of interest, discover biomarkers to stratify patients who could benefit from the drug, and to study the safety and benefit profile of the drug. Furthermore, after the drug is brought to the market its use in broader population is collected in a wide range of real-world data sources including, but not limited to, electronic medical records, disease registries, health insurance claims​, and digital devices​. Thus far the Pharma industry has not leveraged on the wealth of this information to deliver truly personalized care for patients.

Development of advanced ​statistical and machine learning​ methodologies combined with the availability of scalable computing environments is fueling a new wave of digitization in Pharma R&D pipelines thereby creating possibilities to discover and develop personalized medicines. This track would invite experts from industry and academia to share their experiences in using AI/ML for Pharma R&D. 

Track / Schedule

Data Science for Pharma R&D - Opportunities & Challenges

With Asif Jan

Developing Digital Measures from Person-Generated Health Data

With Luca Foschini

Detection and quantification of disease biomarkers in ophthalmology

With Agata Mosinska

Bayesian Neural Networks for toxicity prediction

With Elizaveta Semenova

A Machine Learning perspective on the emotional content of Parkinsonian speech

With Konstantinos Sechidis

On the Stability and Reproducibility of Data Science Pipelines

With Gavin Brown

Break

Going beyond the average: causal machine learning for treatment effect heterogeneity estimation

With Karla DiazOrdaz

AE Brain - Detecting Adverse Drug Events with NLP

With Damir Bucar & Moritz Freidank

Defining and redefining human disease in electronic health records

With Spiros Denaxas

Fully unsupervised deep mode of action learning for phenotyping high-content cellular images

With Rens Janssens

Novartis benchmarking initiative: making sense of AI through the common task framework

With Mark Baillie

Artificial Intelligence in clinical development

With Marco Prunotto

Closing remarks

Track / Speakers

Elizaveta Semenova

Postdoc, AstraZeneca

Spiros Denaxas

Professor of Biomedical Informatics, University College London

Luca Foschini

Co-founder & Chief Data Scientist, Evidation Health

Gavin Brown

University of Manchester

Marco Prunotto

Head of Innovation, Late Stage Development, Roche

Asif Jan

Group Director, PHC Data Science, Roche

Rens Janssens

Research Software Engineer, Novartis

Moritz Freidank

Full Stack Developer, Novartis

Agata Mosinska

Research Scientist, RetinAI Medical

Konstantinos Sechidis

Postdoctoral Research Fellow, Roche

Mark Baillie

Director Statistical Methodology and Consulting, Novartis

Karla DiazOrdaz

The Alan Turing Institute

Damir Bucar

Product Engineer, Novartis

Track / Co-organizers

Asif Jan

Group Director, PHC Data Science, Roche

Kurt Stockinger

Professor, ZHAW - Zurich University of Applied Sciences

AMLD EPFL 2020 / Tracks & talks

AI & Climate Change

Lynn Kaack, Nikola Milojevic-Dupont, Nicholas Jones, Felix Creutzig, Buffy Price, Slava Jankin, Olivier Corradi, Liam F. Beiser-McGrath, Marius Zumwald, Eniko Székely, Max Callaghan, Soon Hoe Lim, Mohamed Kafsi, Daniel de Barros Soares, Matthias Meyer, Chris Heinrich, Emmanouil Thrampoulidis, Marta Gonzalez, Kristina Orehounig, David Dao, Bibek Paudel

13:30-17:00 January 2709:00-12:30 January 285ABC

AI & Humanitarian Action

Neil Davison, Max Tegmark, Carmela Troncoso, Alessandro Mantelero, Michela D'Onofrio, Francois Fleuret, Amina Chebira, John C. Havens, Marc Brockschmidt, Helen Toner, Dustin Lewis, Subhashis Banerjee, Rebeca Moreno Jimenez, Netta Goussac, Volkan Cevher, Anika Schumann, Nadia Marsan, Massimo Marelli, Anja Kaspersen

09:00-17:00 January 283A

AI & Cities

Konstantin Klemmer, Shin Alexandre Koseki, Eun-Kyeong Kim, Nicholas Jones, Kamil Kaczmarek, Kiran Zahra, Roger Fischer, Doori Oh, Ran Goldblatt, Martí Bosch, Roman Prokofyev, Cristina Kadar, Dmitry Kudinov, Camille Lechot, Ellie Cosgrave, Javier Pérez Trufero, Layik Hama, Hoda Allahbakhshi, Marta Gonzalez, Valery Fischer, Emmanouil Tranos, Jens Kandt, Yussuf Said Yussuf, Nyalleng Moorosi, Nick Lucius

09:00-17:00 January 281BC

AMLD / Global partners